Fortrea Holdings (FTRE) Amortization of Deferred Charges (2022 - 2026)

Fortrea Holdings (FTRE) posted Amortization of Deferred Charges of $2.0 million for Q1 2026, down 31.03% on a QoQ basis from $2.9 million in Q4 2025, and down 33.33% year-over-year from $3.0 million in Q1 2025.

Fortrea Holdings (FTRE) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends

Fortrea Holdings' Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $2.0 million for Q1 2026.

  • Quarterly Amortization of Deferred Charges fell 33.33% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (down 2.78% YoY) and the FY2025 annual result came in at $11.5 million, down 17.86% from the prior year.
  • Amortization of Deferred Charges was $2.0 million for Q1 2026 at Fortrea Holdings, down from $2.9 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $8.1 million in Q3 2022 and bottomed at -$1.1 million in Q3 2024.
  • A 5-year average of $4.6 million and a median of $5.7 million in 2024 frame the typical range for Amortization of Deferred Charges.
  • Annual changes were most pronounced in 2024 — Amortization of Deferred Charges plunged 116.67% — and 2025, when it surged 336.36%.
  • Fortrea Holdings' Amortization of Deferred Charges stood at $5.9 million in 2022, then increased by 10.17% to $6.5 million in 2023, then tumbled by 50.77% to $3.2 million in 2024, then declined by 9.38% to $2.9 million in 2025, then tumbled by 31.03% to $2.0 million in 2026.
  • Business Quant data shows FTRE's Amortization of Deferred Charges at $2.0 million in Q1 2026, $2.9 million in Q4 2025, and $2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Mn
Mar 31, 2026 2.00 Mn
Dec 31, 2025 2.90 Mn
Dec 31, 2025 2.90 Mn
Sep 30, 2025 2.60 Mn
Sep 30, 2025 2.60 Mn
Jun 30, 2025 3.00 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 3.00 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 3.20 Mn
Dec 31, 2024 3.20 Mn
Sep 30, 2024 -1.10 Mn
Sep 30, 2024 -1.10 Mn
Jun 30, 2024 5.70 Mn
Jun 30, 2024 5.70 Mn
Mar 31, 2024 6.20 Mn
Mar 31, 2024 6.20 Mn
Dec 31, 2023 6.50 Mn
Dec 31, 2023 6.50 Mn